Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Appointed director
|
|
Sage Therapeutics, Inc. (SAGE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2023 |
4
| Greene Barry E (President and CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 195,000 options to buy
@ $85.82, valued at
$16.7M
|
|
| 06/16/2023 |
4
| Federer Jessica (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| Barrett Elizabeth (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| Germano Geno J (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| STARR KEVIN P (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/16/2023 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 05/11/2023 |
4
| Barrett Elizabeth (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $50.5, valued at
$50.5k
|
|
| 03/17/2023 |
4
| Federer Jessica (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 19,894 options to buy
@ $43.64, valued at
$868.2k
|
|
| 03/17/2023 |
4
| IGUCHI KIMI (CFO & Treasurer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $1.36, valued at
$4.1k
|
|
| 02/23/2023 |
4
| IGUCHI KIMI (CFO & Treasurer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 750 options to buy
@ $1.36, valued at
$1k
Exercised 250 options to buy
@ $1.36, valued at
$340 |
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 5,100 shares
@ $0
Paid exercise price by delivering 1,427 shares
@ $44.16, valued at
$63k
|
|
| 02/07/2023 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 3,375 shares
@ $0
Paid exercise price by delivering 1,127 shares
@ $44.16, valued at
$49.8k
|
|
| 02/07/2023 |
4
| IGUCHI KIMI (CFO & Treasurer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 2,850 shares
@ $0
Paid exercise price by delivering 914 shares
@ $44.16, valued at
$40.4k
|
|
| 02/07/2023 |
4
| Cook Anne Marie (SVP, GC & Secretary) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 2,850 shares
@ $0
Paid exercise price by delivering 980 shares
@ $44.16, valued at
$43.3k
|
|
| 02/07/2023 |
4
| Benecchi Christopher (Chief Business Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 6,750 shares
@ $0
Paid exercise price by delivering 2,119 shares
@ $44.16, valued at
$93.6k
|
|
| 01/11/2023 |
4
| IGUCHI KIMI (CFO & Treasurer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 1,600 options to buy
@ $1.36, valued at
$2.2k
|
|
| 01/05/2023 |
4
| IGUCHI KIMI (CFO & Treasurer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 1,800 options to buy
@ $1.36, valued at
$2.4k
|
|
| 01/05/2023 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 2,395 options to buy
@ $39.16, valued at
$93.8k
|
|
| 01/05/2023 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 2,108 options to buy
@ $39.16, valued at
$82.5k
|
|
| 01/05/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 2,501 options to buy
@ $28.63, valued at
$71.6k
|
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Benecchi Christopher (Chief Commercial Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 9,500 options to buy
@ $31.36, valued at
$297.9k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 9,947 options to buy
@ $31.36, valued at
$311.9k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|